Literature DB >> 20840468

Calcium signalling mediated through α7 and non-α7 nAChR stimulation is differentially regulated in bovine chromaffin cells to induce catecholamine release.

Laura del Barrio1, Javier Egea, Rafael León, Alejandro Romero, Ana Ruiz, Mayte Montero, Javier Alvarez, Manuela G López.   

Abstract

BACKGROUND AND
PURPOSE: Ca(2+) signalling and exocytosis mediated by nicotinic receptor (nAChR) subtypes, especially the α7 nAChR, in bovine chromaffin cells are still matters of debate. EXPERIMENTAL APPROACH: We have used chromaffin cell cultures loaded with Fluo-4 or transfected with aequorins directed to the cytosol or mitochondria, several nAChR agonists (nicotine, 5-iodo-A-85380, PNU282987 and choline), and the α7 nAChR allosteric modulator PNU120596. KEY
RESULTS: Minimal [Ca(2+) ](c) transients, induced by low concentrations of selective α7 nAChR agonists and nicotine, were markedly increased by the α7 nAChR allosteric modulator PNU120596. These potentiated responses were completely blocked by the α7 nAChR antagonist α-bungarotoxin (α7-modulated-response). Conversely, high concentrations of the α7 nAChR agonists, nicotine or 5-iodo-A-85380 induced larger [Ca(2+) ](c) transients, that were blocked by mecamylamine but were unaffected by α-bungarotoxin (non-α7 response). [Ca(2+) ](c) increases mediated by α7 nAChR were related to Ca(2+) entry through non-L-type Ca(2+) channels, whereas non-α7 nAChR-mediated signals were related to L-type Ca(2+) channels; Ca(2+) -induced Ca(2+) -release contributed to both responses. Mitochondrial involvement in the control of [Ca(2+) ](c) transients, mediated by either receptor, was minimal. Catecholamine release coupled to α7 nAChRs was more efficient in terms of catecholamine released/[Ca(2+) ](c) . CONCLUSIONS AND IMPLICATIONS: [Ca(2+) ](c) and catecholamine release mediated by α7 nAChRs required an allosteric modulator and low doses of the agonist. At higher agonist concentrations, the α7 nAChR response was lost and the non-α7 nAChRs were activated. Catecholamine release might therefore be regulated by different nAChR subtypes, depending on agonist concentrations and the presence of allosteric modulators of α7 nAChRs.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20840468      PMCID: PMC3012409          DOI: 10.1111/j.1476-5381.2010.01034.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  57 in total

1.  The role of calcium in the secretory response of the adrenal medulla to acetylcholine.

Authors:  W W DOUGLAS; R P RUBIN
Journal:  J Physiol       Date:  1961-11       Impact factor: 5.182

2.  Mechanism of nicotinic action at the adrenal medulla: calcium as a link in stimulus-secretion coupling.

Authors:  W W DOUGLAS; R P RUBIN
Journal:  Nature       Date:  1961-12-16       Impact factor: 49.962

3.  Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

Authors:  Alice L Bodnar; Luz A Cortes-Burgos; Karen K Cook; Dac M Dinh; Vincent E Groppi; Mihaly Hajos; Nicole R Higdon; William E Hoffmann; Raymond S Hurst; Jason K Myers; Bruce N Rogers; Theron M Wall; Mark L Wolfe; Erik Wong
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

4.  alpha-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with alpha 7 subunits and up-regulation by chronic nicotine treatment.

Authors:  G E Barrantes; A T Rogers; J Lindstrom; S Wonnacott
Journal:  Brain Res       Date:  1995-02-20       Impact factor: 3.252

5.  Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones.

Authors:  Sergio Fucile; Antonietta Sucapane; Fabrizio Eusebi
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

6.  5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors.

Authors:  A G Mukhin; D Gündisch; A G Horti; A O Koren; G Tamagnan; A S Kimes; J Chambers; D B Vaupel; S L King; M R Picciotto; R B Innis; E D London
Journal:  Mol Pharmacol       Date:  2000-03       Impact factor: 4.436

7.  Separate binding and functional sites for omega-conotoxin and nitrendipine suggest two types of calcium channels in bovine chromaffin cells.

Authors:  J J Ballesta; M Palmero; M J Hidalgo; L M Gutierrez; J A Reig; S Viniegra; A G Garcia
Journal:  J Neurochem       Date:  1989-10       Impact factor: 5.372

8.  Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.

Authors:  Jens Halvard Grønlien; Monika Håkerud; Hilde Ween; Kirsten Thorin-Hagene; Clark A Briggs; Murali Gopalakrishnan; John Malysz
Journal:  Mol Pharmacol       Date:  2007-06-12       Impact factor: 4.436

Review 9.  The endoplasmic reticulum and neuronal calcium signalling.

Authors:  A Verkhratsky
Journal:  Cell Calcium       Date:  2002 Nov-Dec       Impact factor: 6.817

10.  Nicotine-induced intracellular calcium changes are not antagonized by alpha-bungarotoxin in adrenal medullary cells.

Authors:  R Afar; J M Trifaró; M Quik
Journal:  Brain Res       Date:  1994-03-28       Impact factor: 3.252

View more
  19 in total

1.  Microtubule dynamics at the growth cone are mediated by α7 nicotinic receptor activation of a Gαq and IP3 receptor pathway.

Authors:  Jacob C Nordman; Nadine Kabbani
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

2.  Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

3.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

4.  Metabolomics Analyses of 14 Classical Neurotransmitters by GC-TOF with LC-MS Illustrates Secretion of 9 Cell-Cell Signaling Molecules from Sympathoadrenal Chromaffin Cells in the Presence of Lithium.

Authors:  Vivian Hook; Tobias Kind; Sonia Podvin; Mine Palazoglu; Carol Tran; Thomas Toneff; Stephanie Samra; Christopher Lietz; Oliver Fiehn
Journal:  ACS Chem Neurosci       Date:  2019-01-23       Impact factor: 4.418

Review 5.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

Review 6.  Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

Authors:  Almudena Albillos; J Michael McIntosh
Journal:  Pflugers Arch       Date:  2017-10-20       Impact factor: 3.657

7.  Pharmacological characterization of native α7 nicotinic ACh receptors and their contribution to depolarization-elicited exocytosis in human chromaffin cells.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; Sergio Alonso Y Gregorio; Angel Tabernero; J Michael McIntosh; Almudena Albillos
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.

Authors:  Kelen Freitas; Sudeshna Ghosh; F Ivy Carroll; Aron H Lichtman; M Imad Damaj
Journal:  Neuropharmacology       Date:  2012-10-16       Impact factor: 5.250

Review 9.  The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

10.  Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.

Authors:  Arik J Hone; Lola Rueda-Ruzafa; Thomas J Gordon; Joanna Gajewiak; Sean Christensen; Tino Dyhring; Almudena Albillos; J Michael McIntosh
Journal:  J Neurochem       Date:  2020-02-11       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.